NMDA receptor blockade prevents nitroglycerin-induced headaches.
Roffey
P
P
Mikhail
M
M
Thangathurai
D
D
D000701:Analgesics, Opioid / Q000627:therapeutic use; D004338:Drug Combinations; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005283:Fentanyl / Q000627:therapeutic use; D006261:Headache / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D007649:Ketamine / Q000627:therapeutic use*; D005996:Nitroglycerin / Q000009:adverse effects*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D014665:Vasodilator Agents / Q000009:adverse effects*
D000701:Analgesics, Opioid; D004338:Drug Combinations; D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D014665:Vasodilator Agents; D007649:Ketamine; D005996:Nitroglycerin; D005283:Fentanyl